首页> 外文学位 >Enhancement of oligodendrocyte remyelination through the ablation of non-muscle myosin II B.
【24h】

Enhancement of oligodendrocyte remyelination through the ablation of non-muscle myosin II B.

机译:通过消融非肌肉肌球蛋白II B增强少突胶质细胞的髓鞘再生。

获取原文
获取原文并翻译 | 示例

摘要

The myelinating cell of the central nervous system, the oligodendrocyte (OL), undergoes a dramatic change in the organization of its cytoskeleton as it differentiates from an oligodendrocyte precursor cell to a myelin forming OL. This change involves an increase in branching, which is required for the OLs ability to myelinate multiple axons.;Our laboratory has shown that levels of non-muscle myosin II (NMII), a regulator of cytoskeletal contractility, decrease as a function of differentiation and that inhibition of NMII activity increases branching and myelination of OL in coculture with neurons. It was also found that mixed glial cultures derived from NMIIB knockout mice display an increase in the number of mature myelin basic protein expressing OL compared to wild type cultures.;These studies have now been extended to investigate the role of NMIIB ablation in myelin repair following focal demyelination by lysolecithin. To this end, we employed an OL-specific inducible knockout model using a PLP driven promoter in combination with a temporally activated CRE-ER fusion protein. The data indicate that conditional ablation of NMII in adult mouse brain, promotes faster lesion resolution and remyelination when compared to that observed in control brains.;Although several pathways have been implicated in oligodendrocyte morphogenesis, their specific contribution to the regulation of NMII activity has not been directly examined. We tested the hypothesis that the activity of NMII in OPC is controlled by Fyn kinase via downregulation of RhoA-ROCK-NMII phosphorylation. The resulting data confirm the function of NMII as a negative regulator of OL maturation and demonstrate that Fyn kinase downregulates NMII activity thus promoting oligodendrocyte morphological differentiation. Furthermore this study provides a novel target for promoting myelin formation and repair in the adult brain.
机译:中枢神经系统的髓鞘细胞少突胶质细胞(OL)在其细胞骨架组织方面发生了巨大变化,因为它从少突胶质细胞前体细胞分化为形成髓鞘的OL。这种变化涉及分支的增加,这是OLs使多轴突发生髓鞘形成的能力所必需的;我们的实验室表明,非骨骼肌肌球蛋白II(NMII)的水平是细胞骨架收缩性的调节剂,随着分化和功能的降低而降低。与神经元共培养时,抑制NMII活性会增加OL的分支和髓鞘化。还发现与野生型培养相比,源自NMIIB基因敲除小鼠的混合神经胶质培养物表达成熟的髓磷脂碱性蛋白的OL数量增加。这些研究现已扩展到研究NMIIB消融在髓鞘修复后的作用溶血卵磷脂可引起局灶性脱髓鞘。为此,我们采用了OL特异性诱导敲除模型,该模型将PLP驱动的启动子与时间激活的CRE-ER融合蛋白结合使用。数据表明,与对照脑相比,有条件的NMII消融在成年小鼠脑中可促进更快的病变消融和髓鞘再生;尽管少突胶质细胞形态发生中涉及多种途径,但它们对NMII活性调节的特定作用尚不明确。经过直接检查。我们测试了以下假设:OPC中NMII的活性受Fyn激酶通过下调RhoA-ROCK-NMII磷酸化的控制。所得数据证实了NMII作为OL成熟的负调节剂的功能,并证明Fyn激酶下调NMII活性,从而促进少突胶质细胞形态分化。此外,这项研究为促进成人脑中髓磷脂的形成和修复提供了新的靶点。

著录项

  • 作者

    Rusielewicz, Tomasz.;

  • 作者单位

    City University of New York.;

  • 授予单位 City University of New York.;
  • 学科 Biology General.;Biology Neuroscience.;Biology Cell.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 89 p.
  • 总页数 89
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号